Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists.

Int J Mol Sci · 2021 · PMC8509708 · PMID 34639160

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

placebo—the difference was apparent at week 6 and remained statistically significant until the end of the treatment (week 12).

also in 830 other papers

did not reach statistical significanceno p-value reported

Trends toward serum leptin, IL-6, and plasminogen activator inhibitor 1 level lowering were also observed but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.